daily oral glp-1 receptor agonist orforglipron for adults with obesity New pill reduces weight in trial Lilly's orforglipron shows promising weight

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial

WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (Protein kinase B)/akt substrate

The most commonly known incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), formerly called Gastric inhibitory peptide ( In view of this, a widespread search of SCOPUS, PubMed, and CENTRAL was performed using the following string (obesity or insulin resistance) AND (tirzepatide or Dual GIP and GLP-1 Receptor Agonist)

Another key benefit is a lower risk of hypoglycemia